Cipla moves forward with deal for plant in Algeria

India's Cipla has said in a filing with the Bombay Stock Exchange that it has completed a move forward with a joint venture in Algeria that will lead to the production of respiratory drugs there. In February, Cipla said that it was creating the JV with Biopharma and that the partners would invest up to $15 million to build a manufacturing plant there, The Economic Times reports. Story

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.